With its Series C now reaching $100 million, Whale, a global enterprise AI company, today announced a $40 million extension as it scales its global enterprise AI deployments. The round was led by CMB ...
Oral PCSK9 inhibitor Lipfendra (enlicitide) won FDA approval July 16, 2026 as the first pill to match injectable cholesterol ...
A dangerous assumption persists that existing commercial insurance portfolios will naturally absorb any liabilities arising ...